Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Gestation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01853046
What this trial is testing

Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment

Who this might be right for
Neoplasms
Bayer 24
Testing effectiveness (Phase 2)Looking for participantsNCT04716686
What this trial is testing

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

Who this might be right for
Endometrial CarcinomaSerous Carcinoma
Shandong University 83
Large-scale testing (Phase 3)Study completedNCT02195986
What this trial is testing

A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis

Who this might be right for
Atrophic Vaginitis
Mylan Pharmaceuticals Inc 366
Not applicableStudy completedNCT03077386
What this trial is testing

Enhancing Community Health Through Patient Navigation, Advocacy and Social Support

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more
University of Calgary 176
Not applicableStudy completedNCT06761742
What this trial is testing

Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests

Who this might be right for
Renal Tumors
RenJi Hospital 1,922
Not applicableUnknownNCT05633342
What this trial is testing

Project CADENCE (CAncer Detected Early caN be CurEd)

Who this might be right for
Thoracic CancerOvarian CancerLiver Cancer+6 more
MiRXES Pte Ltd 15,000
Not applicableActive Not RecruitingNCT06496542
What this trial is testing

Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKD

Who this might be right for
Autosomal Dominant Polycystic Kidney
University of Colorado, Denver 14
Testing effectiveness (Phase 2)WithdrawnNCT04262375
What this trial is testing

Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION

Who this might be right for
Non Small Cell Lung CancerRenal Cell Carcinoma
University Health Network, Toronto
Large-scale testing (Phase 3)Study completedNCT02142075
What this trial is testing

Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure

Who this might be right for
Renal FailureCritical CareGram Positive Bacteria
Poitiers University Hospital
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Large-scale testing (Phase 3)Study completedNCT02627963
What this trial is testing

Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Carcinoma, Renal Cell
AVEO Pharmaceuticals, Inc. 350
Testing effectiveness (Phase 2)UnknownNCT05147493
What this trial is testing

Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal ImpairmentNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 51
Testing effectiveness (Phase 2)Looking for participantsNCT03412877
What this trial is testing

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Who this might be right for
Endocrine TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more
National Cancer Institute (NCI) 285
Post-approval studies (Phase 4)Study completedNCT00798434
What this trial is testing

Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.

Who this might be right for
Urinary Bladder, Overactive
Pfizer 794
Early research (Phase 1)Study completedNCT00856570
What this trial is testing

A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects

Who this might be right for
Overactive BladderPharmacokinetics
Astellas Pharma Inc 24
Not applicableStudy completedNCT02568722
What this trial is testing

Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)

Who this might be right for
Acute Kidney Injury
Unity Health Toronto 3,019
Testing effectiveness (Phase 2)Looking for participantsNCT04503265
What this trial is testing

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more
AtlasMedx, Incorporated 122
Not applicableStudy completedNCT02268786
What this trial is testing

Single Embryo TrAnsfeR of Euploid Embryo

Who this might be right for
InfertilityAneuploidy
Illumina, Inc. 661
Testing effectiveness (Phase 2)Study completedNCT01194973
What this trial is testing

An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome

Who this might be right for
Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc. 44
Not applicableStudy completedNCT03593512
What this trial is testing

Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy

Who this might be right for
Multiple System AtrophyAutonomic FailurePostural Hypotension+2 more
University of Oxford 5
Next Page